Royalty Pharma Stock Options
| RPRX Stock | USD 25.84 0.05 0.19% |
Royalty Pharma's latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.42. The Royalty Pharma option chain provides detailed quote and price information for the current Royalty Pharma Plc option contracts. It shows all of Royalty Pharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Royalty Pharma Maximum Pain Price Across 2025-01-17 Option Contracts
Max pain occurs when Royalty Pharma's market makers reach a net positive position across all Royalty Pharma's options at a strike price where option holders stand to lose the most money. By contrast, Royalty Pharma's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Royalty Pharma
Analyzing Royalty Pharma's in-the-money options over time can help investors to take a profitable long position in Royalty Pharma regardless of its overall volatility. This is especially true when Royalty Pharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Royalty Pharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Royalty Pharma's stock while costing only a fraction of its price.
Royalty Current Options Market Mood
Royalty Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Royalty Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Royalty Pharma's options investors are not very successful. Royalty Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Royalty contract
Base on the Rule 16, the options market is currently suggesting that Royalty Pharma Plc will have an average daily up or down price movement of about 0.0263% per day over the life of the 2025-01-17 option contract. With Royalty Pharma trading at USD 25.84, that is roughly USD 0.006783. If you think that the market is fully incorporating Royalty Pharma's daily price movement you should consider buying Royalty Pharma Plc options at the current volatility level of 0.42%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Royalty |
Purchasing Royalty Pharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Royalty calls. Remember, the seller must deliver Royalty Pharma Plc stock to the call owner when a call is exercised.
Royalty Pharma Option Chain
When Royalty Pharma's strike price is surpassing the current stock price, the option contract against Royalty Pharma Plc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Royalty Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Royalty. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Royalty. It also shows strike prices and maturity days for a Royalty Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | RPRX250117C00015000 | 0 | 15.0 | 12.3 - 16.5 | 12.3 | |
Call | RPRX250117C00017500 | 0 | 17.5 | 10.4 - 14.5 | 10.4 | |
Call | RPRX250117C00020000 | 0 | 20.0 | 8.1 - 12.0 | 8.1 | |
Call | RPRX250117C00022500 | 0 | 22.5 | 6.7 - 10.0 | 6.7 | |
Call | RPRX250117C00025000 | 0 | 25.0 | 4.9 - 8.0 | 4.9 | |
Call | RPRX250117C00027500 | 0 | 27.5 | 2.85 - 6.4 | 2.85 | |
Call | RPRX250117C00030000 | 0 | 30.0 | 2.45 - 5.3 | 2.45 | |
Call | RPRX250117C00032500 | 0 | 32.5 | 1.8 - 3.6 | 2.4 | |
Call | RPRX250117C00035000 | 0 | 35.0 | 0.65 - 2.6 | 0.65 | |
Call | RPRX250117C00037500 | 0 | 37.5 | 0.25 - 2.25 | 0.25 | |
Put | RPRX250117P00015000 | 0 | 15.0 | 0.0 - 3.0 | 3.0 | |
Put | RPRX250117P00017500 | 0 | 17.5 | 0.1 - 2.75 | 0.1 | |
Put | RPRX250117P00020000 | 0 | 20.0 | 0.1 - 3.5 | 0.1 | |
Put | RPRX250117P00022500 | 0 | 22.5 | 0.3 - 3.4 | 0.3 | |
Put | RPRX250117P00025000 | 0 | 25.0 | 0.6 - 2.75 | 0.6 | |
Put | RPRX250117P00027500 | 0 | 27.5 | 1.95 - 3.0 | 1.95 | |
Put | RPRX250117P00030000 | 0 | 30.0 | 2.35 - 4.6 | 2.35 | |
Put | RPRX250117P00032500 | 0 | 32.5 | 4.1 - 6.4 | 4.1 | |
Put | RPRX250117P00035000 | 0 | 35.0 | 6.2 - 8.5 | 6.2 | |
Put | RPRX250117P00037500 | 0 | 37.5 | 8.4 - 10.9 | 8.4 |
Royalty Total Stockholder Equity
Total Stockholder Equity |
|
Royalty Pharma Corporate Management
| Eric Schneider | Senior Officer | Profile | |
| George Lloyd | Executive Officer | Profile | |
| Marshall MD | Executive Investments | Profile | |
| Sandy Balkin | Senior Analytics | Profile | |
| Sara Klymkowsky | Senior Investments | Profile | |
| Ashwin MD | Executive Investments | Profile |
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.